0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters to the Editor   |    
Dr. Pope Replies
HARRISON G. POPE
Am J Psychiatry 2009;166:1188-1188. doi:10.1176/appi.ajp.2009.09060846r

To the Editor: We agree with virtually all of the points raised by Drs. Scally and Tan, except for a minor semantic issue regarding their suggestion that anabolic steroid-induced hypogonadism represents a possible “confounding variable” in the diagnosis of anabolic-androgenic steroid dependence. To explain, we need to carefully define our terms. Anabolic steroid-induced hypogonadism is certainly a common physiologic response to chronic anabolic-androgenic steroid exposure, and it may contribute to anabolic-androgenic steroid withdrawal symptoms. Withdrawal symptoms, in turn, are a cluster of physical and psychological symptoms that may occur after discontinuing a drug that induces physiological dependence. Withdrawal symptoms are only one of the seven DSM-IV criteria for substance dependence and are neither necessary nor sufficient for a DSM-IV diagnosis of substance dependence. With these definitions in mind, then, we would say that anabolic steroid-induced hypogonadism represents simply one underlying mechanism for the etiology of anabolic-androgenic steroid withdrawal symptoms and should not be considered a confounder for making a DSM-IV diagnosis of anabolic-androgenic steroid dependence.

As an example, opioid withdrawal is caused in part by abnormal signaling at central opioid receptors (1). However, this abnormal receptor activity is not a “confounding variable” in diagnosing opioid dependence. Rather, it is one of the underlying mechanisms of opioid withdrawal, and opioid withdrawal, in turn, is a frequent (but not necessary) criterion for diagnosing opioid dependence. Similarly, if an anabolic-androgenic steroid user suppresses his own testosterone production as a result of prolonged exogenous anabolic-androgenic steroid administration and then develops consequent hypogonadal symptoms upon withdrawing (2), these withdrawal symptoms would legitimately count as one criterion (although not a necessary criterion) for the diagnosis of anabolic-androgenic steroid dependence.

On the basis of these considerations, we would agree with Drs. Scally and Tan that anabolic steroid-induced hypogonadism needs to be differentiated from anabolic-androgenic steroid dependence, since not all patients who suffer from anabolic steroid-induced hypogonadism will qualify for a diagnosis of anabolic-androgenic steroid dependence. However, we would suggest that anabolic steroid-induced hypogonadism does not disqualify an individual from a diagnosis of anabolic-androgenic steroid dependence either. Instead, anabolic steroid-induced hypogonadism represents one of the primary mechanisms of anabolic-androgenic steroid withdrawal and physiological dependence.

1. Waldhoer M, Bartlett SE, Whistler JL: Opioid receptors. Annu Rev Biochem 2004; 73:953–990
 
2. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG: Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009 (in press)
 
+

References

+The author’s disclosures accompany the original editorial.

+This letter (doi: 10.1176/appi.ajp.2009.09060846r) was accepted for publication in July 2009.

+

References

1. Waldhoer M, Bartlett SE, Whistler JL: Opioid receptors. Annu Rev Biochem 2004; 73:953–990
 
2. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG: Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009 (in press)
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 17.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 17.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 17.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 18.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 17.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles